240 related articles for article (PubMed ID: 21890814)
61. COX-2 expression in adenoma: an imperfect marker for chemoprevention.
Chan AT
Gut; 2010 May; 59(5):568-9. PubMed ID: 20427388
[No Abstract] [Full Text] [Related]
62. The adenoma prevention with celecoxib and prevention of colorectal sporadic adenomatous polyps trials: stepping stones to progress.
Hawk E; Viner JL
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):185-7. PubMed ID: 17301246
[No Abstract] [Full Text] [Related]
63. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
64. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
[TBL] [Abstract][Full Text] [Related]
65. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group.
Greenberg ER; Baron JA; Tosteson TD; Freeman DH; Beck GJ; Bond JH; Colacchio TA; Coller JA; Frankl HD; Haile RW
N Engl J Med; 1994 Jul; 331(3):141-7. PubMed ID: 8008027
[TBL] [Abstract][Full Text] [Related]
66. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps.
Weingarten MA; Zalmanovici A; Yaphe J
Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD003548. PubMed ID: 18254022
[TBL] [Abstract][Full Text] [Related]
67. Baseline dietary fiber intake and colorectal adenoma recurrence in the wheat bran fiber randomized trial.
Jacobs ET; Giuliano AR; Roe DJ; Guillén-Rodríguez JM; Alberts DS; Martínez ME
J Natl Cancer Inst; 2002 Nov; 94(21):1620-5. PubMed ID: 12419788
[TBL] [Abstract][Full Text] [Related]
68. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
[TBL] [Abstract][Full Text] [Related]
69. The effect of calcium and vitamin supplements on the incidence and recurrence of colorectal adenomatous polyps.
Neugut AI; Horvath K; Whelan RL; Terry MB; Garbowski GC; Bertram A; Forde KA; Treat MR; Waye J
Cancer; 1996 Aug; 78(4):723-8. PubMed ID: 8756363
[TBL] [Abstract][Full Text] [Related]
70. The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma.
Chan AT; Hsu M; Zauber AG; Hawk ET; Bertagnolli MM
Cancer Prev Res (Phila); 2012 Jan; 5(1):61-72. PubMed ID: 22030088
[TBL] [Abstract][Full Text] [Related]
71. Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial.
Bonelli L; Puntoni M; Gatteschi B; Massa P; Missale G; Munizzi F; Turbino L; Villanacci V; De Censi A; Bruzzi P
J Gastroenterol; 2013 Jun; 48(6):698-705. PubMed ID: 23065023
[TBL] [Abstract][Full Text] [Related]
72. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
[TBL] [Abstract][Full Text] [Related]
73. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas.
Ho GY; Xue X; Cushman M; McKeown-Eyssen G; Sandler RS; Ahnen DJ; Barry EL; Saibil F; Bresalier RS; Rohan TE; Baron JA
J Natl Cancer Inst; 2009 Dec; 101(23):1650-4. PubMed ID: 19822838
[TBL] [Abstract][Full Text] [Related]
74. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
Taha AS; McCloskey C; Prasad R; Bezlyak V
Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
[TBL] [Abstract][Full Text] [Related]
75. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.
Winawer SJ; Zauber AG; O'Brien MJ; Ho MN; Gottlieb L; Sternberg SS; Waye JD; Bond J; Schapiro M; Stewart ET
N Engl J Med; 1993 Apr; 328(13):901-6. PubMed ID: 8446136
[TBL] [Abstract][Full Text] [Related]
76. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
Beresford SA; Johnson KC; Ritenbaugh C; Lasser NL; Snetselaar LG; Black HR; Anderson GL; Assaf AR; Bassford T; Bowen D; Brunner RL; Brzyski RG; Caan B; Chlebowski RT; Gass M; Harrigan RC; Hays J; Heber D; Heiss G; Hendrix SL; Howard BV; Hsia J; Hubbell FA; Jackson RD; Kotchen JM; Kuller LH; LaCroix AZ; Lane DS; Langer RD; Lewis CE; Manson JE; Margolis KL; Mossavar-Rahmani Y; Ockene JK; Parker LM; Perri MG; Phillips L; Prentice RL; Robbins J; Rossouw JE; Sarto GE; Stefanick ML; Van Horn L; Vitolins MZ; Wactawski-Wende J; Wallace RB; Whitlock E
JAMA; 2006 Feb; 295(6):643-54. PubMed ID: 16467233
[TBL] [Abstract][Full Text] [Related]
77. Vitamin and calcium supplement use is associated with decreased adenoma recurrence in patients with a previous history of neoplasia.
Whelan RL; Horvath KD; Gleason NR; Forde KA; Treat MD; Teitelbaum SL; Bertram A; Neugut AI
Dis Colon Rectum; 1999 Feb; 42(2):212-7. PubMed ID: 10211498
[TBL] [Abstract][Full Text] [Related]
78. Nonsteroidal anti-inflammatory drug use and risk of adenomatous and hyperplastic polyps.
Murff HJ; Shrubsole MJ; Chen Z; Smalley WE; Chen H; Shyr Y; Ness RM; Zheng W
Cancer Prev Res (Phila); 2011 Nov; 4(11):1799-807. PubMed ID: 21764857
[TBL] [Abstract][Full Text] [Related]
79. Folic acid and risk of prostate cancer: results from a randomized clinical trial.
Figueiredo JC; Grau MV; Haile RW; Sandler RS; Summers RW; Bresalier RS; Burke CA; McKeown-Eyssen GE; Baron JA
J Natl Cancer Inst; 2009 Mar; 101(6):432-5. PubMed ID: 19276452
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
